Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders

Background: Rare cancers occur with an incidence of no more than six cases per 100,000 people according to the definition used by the Surveillance of Rare Cancers in Europe project. For a variety of reasons (low prevalence, cytotoxicity), it is challenging to perform the necessary clinical studies t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dooms, M, Saesen, R, Steemans, I, Lansens, J, Huys, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108391/
https://www.ncbi.nlm.nih.gov/pubmed/35586057
http://dx.doi.org/10.3389/fphar.2022.775217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108391/
https://www.ncbi.nlm.nih.gov/pubmed/35586057
http://dx.doi.org/10.3389/fphar.2022.775217

Ejemplares similares